Ignite Creation Date:
2024-05-06 @ 3:13 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04557956
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2020-09-18
Brief Title:
Testing the Addition of the Anti-cancer Drug Tazemetostat to the Usual Treatment Dabrafenib and Trametinib for Metastatic Melanoma That Has Progressed on the Usual Treatment
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-19
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-04
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-18
First Submit QC Date:
September 18 2020
Study First Post Date:
2020-09-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-08
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL